Amplify Treatments, Testing and Advancements ETF (GERM) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free GERM Stock Alerts $16.90 +0.26 (+1.56%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmplify Treatments, Testing and Advancements ETF (NYSEARCA:GERM) Trading 1.8% Higher americanbankingnews.com - April 23 at 2:16 AMETFMG Treatments Testing and Advancements ETFthestreet.com - February 11 at 10:26 PMETFMG Treatments, Testing and Advancements ETF declares $0.0522 dividendmsn.com - December 28 at 12:29 PMGERM ETFMG Treatments, Testing and Advancements ETFseekingalpha.com - August 25 at 8:21 AMETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0600msn.com - June 23 at 2:00 PMCutting-edge advances in cancer treatment are underway. Here are 3 that could change lives.usatoday.com - April 25 at 7:40 AMJP Morgan Maintains Moderna (MRNA) Neutral Recommendationmsn.com - April 11 at 12:16 AMLactose Intolerance Treatment Market Growth by 2031marketwatch.com - March 24 at 11:38 AMLatest "Blood Culture Test Market" Insights, Trends & Future Development Status Recorded During 2023-2028marketwatch.com - March 8 at 2:56 AMRising Lighting Testing, Inspection and Certification (TIC) Market 2023: Advancements in Near Future and Regional Growth by 2028marketwatch.com - February 21 at 8:46 AMPhage Therapy Market is Exhibit a CAGR of 17.6% By Product Type, Application, Key Players and Forecast to 2027 | Report [125 Pages]marketwatch.com - September 21 at 7:32 PMElectrophysiological Medical Equipment Market 2021 Huge Demand, Growth Opportunities and Expansion by 2028marketwatch.com - August 25 at 12:12 PMEnteric Disease Testing Devices Market Research Report Analysis by Competitors, Sales, Revenue, and Market Size 2022 To 2028.marketwatch.com - July 14 at 12:39 PMGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market 2022 Company Challenges, Latest Advancements, Growth Prediction, and Forecast by 2028marketwatch.com - July 6 at 10:16 PMGlobal Enteric Disease Testing Market Size is Projected to Reach USD 2.45 billion by 2026benzinga.com - July 5 at 8:12 AMargenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europefinance.yahoo.com - June 24 at 2:00 AMGenetic Testing Market is projected to reach USD 36.11 Billion by 2030, growing at a CAGR of 10%: Straits Researchfinance.yahoo.com - June 16 at 6:10 PMGene Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)finance.yahoo.com - June 9 at 10:33 PMGlobal ADME-Toxicology Testing Market to Reach US$11.1 Billion by the Year 2026finance.yahoo.com - May 24 at 10:53 PMDon’t expect vaccine makers’ shares to jump despite ongoing demand for boosters, treatmentstheglobeandmail.com - February 16 at 6:15 AMHealthcare Emerges as Best Sector of Last Week: 5 Top ETFsnasdaq.com - December 20 at 2:32 PMModerna ETFs to Rally on Positive COVID-19 Booster Shot Newsmsn.com - November 22 at 3:38 PMHow to invest in the future of vaccinesafr.com - September 28 at 9:03 PMExpert reveals top pandemic ETF play – up 58% in 12 monthsmsn.com - September 22 at 1:35 AMSogoTrade Reviewinvestopedia.com - September 2 at 10:02 PM5 Must-Watch ETF Charts of Q2 Earningsnasdaq.com - August 27 at 5:08 PM Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better. Click here to find out that this 8,788% cryptocurrency is. GERM Media Mentions By Week GERM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERM News Sentiment▼0.000.53▲Average News Sentiment GERM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERM Articles This Week▼10▲GERM Articles Average Week Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Future Fund Active ETF News B.A.D. Etf News IQ Healthy Hearts ETF News SPAC and New Issue ETF News Enact News Tema Luxury ETF News Capital Link Global Fintech Leaders ETF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:GERM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
